Not really, according to a study in the Journal of the American Medical Association (10/12/05). The study compared the impact of a pay-for-performance program on quality of care within two sets of physician groups within PacifiCare Health Systems. The study involved an intervention group, which received bonuses for meeting or exceeding 10 clinical and service quality targets, and a comparison group. Both groups were assessed against three measures: cervical cancer screening, mammography, and hemoglobin A1c testing.
Not really, according to a study in the Journal of the American Medical Association (10/12/05). The study compared the impact of a pay-for-performance program on quality of care within two sets of physician groups within PacifiCare Health Systems. The study involved an intervention group, which received bonuses for meeting or exceeding 10 clinical and service quality targets, and a comparison group. Both groups were assessed against three measures: cervical cancer screening, mammography, and hemoglobin A1c testing.
The researchers found that improvements in all three quality measures occurred in both the intervention group and comparison group. However, only the improvement in cervical cancer screening was significantly greater in the intervention group than the comparison group. Interestingly, the researchers also found that the physician groups whose performance was initially the lowest had the most improvement. In contrast, those groups that had already achieved the targeted performance level maintained the status quo and showed the least improvement. The researchers concluded that paying for performance may produce few gains in quality for the money spent and that the current system rewards practices that already meet target goals even before a quality incentive program is implemented.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More